Quick answers
- What is Tezruly?
- Tezruly is a brand name of Terazosin hydrochloride, a prescription medicine. The FDA NDC Directory lists 1 Tezruly product in 1 strength and form.
- Who makes Tezruly?
- Novitium Pharma holds the FDA application for Tezruly (NDA218139, approved July 29, 2024).
- Is there a generic or store brand of Tezruly?
- Other products of Terazosin hydrochloride are listed with the FDA, but none in exactly the same strength and form as a Tezruly product.
- Has Tezruly been recalled?
- No recall linked to Tezruly products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Tezruly is
Each Tezruly product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Terazosin hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| terazosin hydrochloride 1 mg/mL solution (oral) | Tezruly | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Terazosin hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA218139 | Novitium Pharma | July 29, 2024 | 1 |
Companies that list Tezruly
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Tezruly products.
- ANI Pharmaceuticals, Inc.1 product
Recalls
No recall linked to Tezruly products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.